76-43-7 Fluoxymesterone
" Ma keʻano bodybuilding, pehea e koho ai i kahi mau steroids pono no bodybuilding he nīnau e nīnau, a aia kekahi ma MuscleTalk,ʻo ia ke koho i ka hanana hōʻaho (PCT) mau lāʻau like me Clomid, Nolvadex a me Letrozole,'Aromasin, Halotestin, Anastrozole pono.Woday e hoʻomaka mākou e aʻo iāʻoe pehea e koho ai i nā lāʻau kūpono PCT. "

He aha ia Nā lāʻau PCT?

ʻO ka Post cycle therapy (PCT) kahi hana o ka hoʻohana ʻana i nā lāʻau e hana ai ma o nā ʻano hana like ʻole e hele ai, kahi hana e pili ana i nā hui kikoʻī, nā meaʻai, a me nā lāʻau lapaʻau pinepine e kōkua i ka mālama ʻana i nā pae o ka estrogen, hoʻoponopono hou i nā pae hormonal a hoʻihoʻi iā ʻoe i ka maʻamau ma hope o ke kaʻapuni o prohormones / steroid. ʻO ka hapa nui o nā steroid anaboliko, keu hoʻi nā androgens, ke kumu o ka pāpā ʻana i ka hana testosterone ponoʻī o ke kino. Ke hele mai kahi bodybuilder mai kahi pōʻai steroid, kūlohelohe testosterone ʻo ka hanaʻana he meaʻole aʻo ka nui o nā steroids i laweʻia i loko o ke koko e ho'ēmi ana. Hiki ke waiho i ka lakio o ka catabolic: nā hormones anabolic i ke koko kiʻekiʻe, no laila ke kino i loko o ka moku catabolic, a, ma muli o ka hopena, e lilo ana ka nui o nāʻiʻo i loaʻa ma ka holomua e nalowale. Pēlā, E lilo anaʻo PCT i mea pono inā bodybuilding. Eia nā ʻona PCT ʻeono, ke hoʻolauna nei mākou iā lākou a me kā lākou hana ʻokoʻa i ka PCT.


Nā lāʻau PCT Nolvadex 

54965-24-1 Kēnā Kūmole

ʻO Nolvadex, ka mea i kapaʻiaʻo Tamoxifen Citrate,ʻo ia ka lāʻau lapaʻau o ka nolvadex i ka wā mua a me ka maiʻana o ka umauma āpau i mua a hoʻouna i nā wāhine menopausal. Hanaʻia e like me ka PCT mau lāʻau no ka bodybuilding,

Hoʻohana maikaʻi ʻia ʻo Nolvadex e kōkua i ka hoʻonui ʻana i ka LH a me ka nui o ka testosterone. E kōkua kēia iā ʻoe e hoʻi mai i kahi pōʻaiapuni, kahi e lilo ai ia i mea koho nui ʻia no ka lāʻau hope o ka pōʻaiapuni (PCT). ʻO kahi clomiphene, hoʻohui tamoxifen kekahi o nā koho hoʻōla maikaʻi loa no ka hapa nui o nā regiment PCT. Ke holo ka mea hoʻohana i nā steroid anabolic, ʻike ka pituitary ke loaʻa nei ka nui o ka hormone, no laila hele ka hiamoe. a hana hou ʻole ke kino i kāna testosterone ponoʻī; i nā ʻōlelo maʻalahi, pio kāu hana testosterone maoli.

Pehea ʻo Nolvadex woks? Hana ia ma ka hoʻonāukiuki ʻana i ka hypophysis e hoʻokuʻu i nā gonadotropins hou aʻe. Hana ia ma ke kāpae ʻana i ka estrogen mai ka hele ʻana i ka pituitary, nāna e hoʻopololei iā ia e hana i ka LH. . A ʻo kahi hopena, kōkua nā pōmaikaʻi Nolvadex iā ʻoe e hōʻemi i nā nalowale o nā loaʻa muscle a hiki i kou kino ponoʻī ke ola.


Nā lāʻau PCT Clomid

ʻO Clomid, i kapaʻiaʻo Clomiphene Citrate, he SERM (ke kohoʻana o ka modulator receptor modulator), e like me tamoxifen (nolvadex). He lāʻau lapaʻau maʻamau ia e hoʻohanaʻia ai no ka uluʻana o ka'ōpū, a he mea pono ia no ka poʻe i pāpikiʻole.

E like me nolvadex, Clomid woks e ka hoʻoulu ʻana i ka hypophysis e hoʻokuʻu i nā gonadotropins hou aku. ʻO nā Gonadotropins he mau pūmua protein i hūnā ʻia e nā hunaola gonadotrope o ka pituitary gland a hoʻoulu i ka wikiwiki a me ke kiʻekiʻe o ka hoʻokuʻu ʻana o ka hormone follicle (FSH) a me ka hormone luteinizing (LH). Ke piʻi ka piʻi o nā gonadotropins, piʻi ka piʻi ʻana o ka LH i ka nui o nā pae testosterone e ʻae ana i ka mea hoʻohana e mālama kūlike i nā kiʻekiʻe testosterone a hiki i ka hiki i ko lākou kino pono ke hoʻōla, a laila mālama i nā loaʻa. ʻO kēia ke kumu i makemake nui ʻia ai ʻo clomid i ka post cycle therapy. (PCT) i waena o ka poʻe e pōʻaiapuni ana i nā anabolic steroid.


Nā lāʻau PCT Letrozole 

ʻO Letrozole, inoa inoa, Femara.ʻO kēia lāʻau i hoʻohanaʻia no ka mālamaʻana i kekahiʻano o ke kanulau maʻi (e like me ka maʻi kanesa āpau) -i ka wahine ma hope o ka maleopause. Eia kekahi, hoʻohanaʻia no nā lāʻau PCT, e hoʻemiʻia ka nui o ka estrogen e ka kino a me ke kōkua e hōʻemi i ka hopena o ka wahine.

ʻO Letrozole (ʻekolu hanauna) kahi koho steroidal koho ʻole ʻekolu i hana ʻia e like me Arimadex ʻaʻole e hāʻawi i nā hopena androgenic. Ua like loa ia me Arimadex no ke aha i kapa ʻia ai lāua ʻelua ʻo Type2 non-sterodial hoʻokūkū aromatase mea kāohi. ʻO ka ʻokoʻa nui ma waena o Femara a me Arimadex ʻoi aku ka ikaika o ka Femara, a me ke kumukūʻai hoʻokūkū. ʻO nā pōmaikaʻi o ka letrozole ʻo ia inā e hoʻomaka ana ka hoʻonāukiuki ʻana o ka estrogen i nā kiko o ka umauma o ka umauma, letro inā hōʻike ʻia i ka manawa e hoʻomaʻemaʻe i nā pilikia. ma ka lima, e hiki ke hemo i ka gyno. E hoʻomanaʻo mai hoʻohana i ka wā o PCT ma ke ʻano he mea hōʻino ia i ka libido a me nā lipids o kekahi, aia wale nō i ka wā o ka pōʻaiapuni a e ʻoluʻolu e akahele me ia mai ka anti-estrogenic nui loa.


Nā lāʻau PCT  ʻO'Aromana

ʻO'Aromas, i kapaʻiaʻo Exemestane,

He mea kāohi ʻo Aromatase suicidal nāna e kāpae i ka Aromatase Enzyme mai ka hoʻokumu ʻana iā Estrogen i kapa ʻia he Aromatase Inhibitor. Eia kekahi, he steroidal AI ia e mālama iā ia mai ka hopena maikaʻi ʻole i kāu lipids e like me nā AC non-steroidal ʻē aʻe. ʻAʻole ia he ʻona kaakea, a hiki ke holo no nā lōʻihi lōʻihi o ka manawa me ka ʻole o ka hopena maikaʻi ʻole ʻo ia kekahi o nā koho i makemake nui ʻia no bodybuilders.

Pehea e hana ai ʻo Aromasin? ʻAʻole ia e luku loa i ka estrogen a hoʻopau ia i ka ʻāpana e hoʻopili ai i ka mea loaʻa. E pale ʻo Nolva i ka estrogen mai ka hoʻopaʻa ʻana i ka mea loaʻa. … Ke lana mau nei kēlā estrogen āpau a puni ke kūkulu ʻia ʻana. No laila ke hele mai ʻoe hiki iā ia ke hoʻomaka ke hoʻopaʻa hou a hāʻawi iā ʻoe iā Gyno rebound. Hiki iā ʻoe ke hoʻohana i ka aromasin ma loko o ka pōʻaiapuni a me ka pct.


Nā lāʻau PCT Halotestin

76-43-7 Fluoxymesterone

ʻO Halotestin, i kapaʻiaʻo Fluoxymesterone.ʻO ka fluoxymesterone he mea hoʻohālike anabolic androgenic anabolic i hoʻohanaʻia i ka mālamaʻana i ka hypogonadism a iʻole nā ​​haʻawina testosterone haʻahaʻa i loko o nā kāne no nā makahiki.

Hoʻohanaʻia nō hoʻi i ka mālamaʻana i nā wā'ōpiopio o ke kāne a me ka mālamaʻana i nā neoplasma umauma.

Eia nō naʻe, no ka mea ua hoʻohālikelike ʻia ʻo fluoxymesterone me he androgen, ʻo ka hana nui a Halotestin a i ʻole ke ʻano o ka hana e hoʻokau a hoʻopaʻa i nā androgen receptor.

No kēia kumu, ua kapaʻia ia he "agonist receptor" androgene; e noʻonoʻo i ka mea iʻoi aku ma keʻano he mea hoʻonā e hoʻomaka ana i nā hana o androgens.

Aʻo nā Androgens he mau hormones kāne ia e hoʻoikaika ana i ka uluʻana a me ka mālamaʻana i nāʻano kāne kāne. Eia hou, hiki ke:

  • Hoʻonui i ka anabolic o nā protein
  • ʻO ka'āpana pōʻaha o ka amino acids
  • Hoʻonui i ka mālamaʻana i nā pale kaukamai waiwai nui e like me ka mea pālolo, phosphorus, a me ka hauʻona
  • E hōʻemi a / aʻaʻaʻana i nā kuʻina o ka estrogen
  • ʻO ka hikiʻana o ka fluoxymesterone e hōʻemi ai i nā kahe o ka estrogen o kekahi o nā kumu nui i hoʻohanaʻia i ka mālamaʻana i nā maʻi maʻi umauma wahine.

Nā lāʻau PCT Anastrozole

Anastrozole heʻano hoʻolālā kūponoʻo 2 non-steroidal ka mea hoʻonāuki kūpono (ʻelua o nā hanauna) e hana ana ma ke kāohiʻana i ka enzyme aromatase (P450 chromosome), ka enzyme pāʻoihana no ka hoʻohuliʻana o ka testosterone i ka estrogen..It hiki ke hoʻonui i ka testosterone, estrogen (lower) nui loa), a mālama i nā hui ola a me ka lipid.

Hana ʻo Arimidex ma ka hoʻoulu ʻana i ka hana testosterone maoli ʻo ia ka manaʻo a me ke kumu e hana ai ʻoe i kahi hoʻolālā PCT a e hana ia i kahi kekelē nui loa. Eia nō naʻe, e like me kona ʻano e hoʻoliʻiliʻi loa ia i ka nui o ka estrogen i loko o ke kino a i loko o ka wā PCT ʻaʻole ka pahuhopu e hoʻomaka hou i ka hana testosterone maoli akā e hiki ai i ko mākou kino ke hoʻi i kā lākou pae maʻamau o ka hana ʻana o ka hormone. ʻIke pinepine ʻia ʻo Estrogen ma ke ʻano he ʻenemi akā ʻo ka ʻoiaʻiʻo he hōmona koʻikoʻi nui ia i ke kino, keu hoʻi ke noʻonoʻo mākou i kona mea nui i ka mālama ʻana i kahi ʻōnaehana pale pale. No kēia kumu, he koho ʻoi aku ka maikaʻi ʻo SERMs e lawelawe i ke kumu o ka hoʻoulu ʻana i ka hana testosterone maoli i ka wā o kahi hoʻolālā PCT; He koho maikaʻi loa nā SERM e like me Nolvadex a me Clomid. A ʻo ke kumu kūʻai, ʻoi aku ke kiʻekiʻe ma mua o nā lāʻau mua ʻekolu a mākou i hoʻopili ai i ka hoʻomaka o ka paukū. Eia nō naʻe, ʻaʻohe kānalua he ikaika ka Arimadex ma ke ʻano he block ma mua o 95. % o ka estrogen ma waena o nā piko, kokoke i Letro akā ʻaʻole ikaika loa.


ʻO AASraw ka mea hana loea o nā lāʻau lapaʻau PCT: Nolvadex, Clomid, Letrozole, Aromasin, Halotestin nona ka hale kūʻokoʻa kūʻokoʻa a me ka hale hana nui e like me ke kākoʻo, e hana ʻia nā hana āpau ma lalo o ke kānāwai CGMP a me ka ʻōnaehana mālama maikaʻi. Paʻa ka ʻōnaehana hoʻolako, ʻae ʻia nā kauoha kūʻai a me nā mea kūʻai.

E kiʻi mai iaʻu i kēia manawa

Mea kākau o kēia ʻatikala:

Kauka Monique Ua puka 'o Hong mai ke Kula Nui o UK Imperial College London Faculty of Medicine

Mea kākau moʻolelo puke moʻolelo ʻepekema:

1.DA Paduch
Urology and Reproductive Medicine, Weill Medical College of Cornell University, New York, NY 
2. Paul G McDonough MD
Keʻena o Obstetrics and Gynecology, Ke Kulanui Lapaʻau o Georgia, Augusta, Georgia USA
3.Floris Bosch
Keʻena o ka Lapaʻau Kuloko, Tergooi Medical Center, Hilversum, Netherlands
4. Hyun Been Jo
Pusan ​​National University Graduate School, Busan, South Korea

5.JM Nabholtz

Ke Kulanui o Kaleponi ma Los Angeles, USA

6.B. Thürlimann

Senology Center o Eastern Switzerland, no ka Swiss Group no Clinical Cancer Research SAKK (Peresidena: A Goldhirsch), Senology Center o Eastern Switzerland, Switzerland
ʻAʻole ʻae kēia kauka/ ʻepekema i ke kūʻai, kūʻai ʻana, a hoʻohana paha i kēia huahana no kekahi kumu. ʻAʻohe pili a pili ʻole ʻo Aasraw, i hōʻike ʻia a i ʻole, me kēia kauka. ʻO ke kumu o ka haʻi ʻana i kēia kauka, ʻo ia ka hoʻomaikaʻi, hoʻomaikaʻi a hoʻomaikaʻi i ka hana noiʻi a me ka hoʻomohala piha i hana ʻia e nā ʻepekema e hana nei i kēia mea.

E hoʻomaopopo '

[1] Rodriguez KM, Pastuszak AW, Lipshultz LI (ʻAukake 2016). "Enclomiphene citrate no ka mālama ʻana i ka hypogonadism kāne lua". Manaʻo loea ma Pharmacotherapy. 17 (11): 1561–7.

[2] Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA (Kekemapa 2013). "Ovulation-inducing drugs a me ovarian cancer risk: results from a long follow-up of a large United States infertility cohort". ʻO ka momona a me ka maʻemaʻe. 100 (6): 1660–6.

[3] Miller GD, Moore C, Nair V, Puʻu B, Willick SE, Rogol AD, Eichner D (Malaki 2019). "Hypothalamic-Pituitary-Testicular Axis Effects a me ka ʻike ʻana i ka urinary ma hope o ka hoʻokele Clomiphene i nā kāne". ʻO ka Journal of Clinical Endocrinology and Metabolism. 104 (3): 906–914.

[4] Hormone a me ka maʻi maʻi umauma. Elsevier. 25 Iune 2013. p. 13–.

[5] Rambhatla A, Mills JN, Rajfer J (2016). "ʻO ke kuleana o nā Estrogen Modulators i ke kāne Hypogonadism a me ka Infertility". Nānā ma Urology. 18 (2): 66–72.

[6] "Soltamox-tamoxifen citrate wai". DailyMed. Ua kiʻi ʻia i ka lā 12 Kepakemapa 2021.

[7] Kuhl H (ʻAukake 2005). "Pharmacology o estrogens a me progestogens: ka hopena o nā ala like ʻole o ka hoʻokele". Climacteric. 8 (Suppl 1): 3–63.

[8] Binkhorst L, Mathijssen RH, Jager A, van Gelder T (Malaki 2015). "Ka hoʻokaʻawale ʻana o ka tamoxifen therapy: ʻoi aku ka nui ma mua o ka CYP2D6 genotyping". Nā Manaʻo Lapaʻau maʻi maʻi. 41 (3): 289–299.

[9] Li J, Ma Z, Jiang RW, Wu B (Sepatemaba 2013). "Hormone-related pharmacokinetic variations e pili ana i nā lāʻau lapaʻau anti-breast cancer". Manaʻo loea e pili ana i ka lāʻau Metabolism & Toxicology. 9 (9): 1085–1095.

[10] Zarate CA, Manji HK (2009). "Nā mea hoʻopiʻi protein kinase C: kumu no ka hoʻohana a me ka hiki ke mālama i ka maʻi bipolar". Laau CNS. 23 (7): 569–582.

[11] Brauch H, Mürdter TE, Eichelbaum M, Schwab M (ʻOkakopa 2009). "Pharmacogenomics o ka tamoxifen therapy". Kemikini Kālā. 55 (10): 1770–1782.

[12] Sanford M, Plosker GL (2008). "Anastrozole: kahi loiloi o kona hoʻohana ʻana i nā wahine postmenopausal me ka maʻi maʻi umauma mua". ʻO nā lāʻau lapaʻau. 68 (9): 1319–1340.

[13] Russell N, Cheung A, Grossmann M (ʻAukake 2017). "Estradiol no ka hoʻohaʻahaʻa ʻana i nā hopena maikaʻi ʻole o ka androgen deprivation therapy". Ka maʻi maʻi maʻi endocrine. 24 (8): R297–R313.

[14] Neyman A, Eugster EA (Kekemapa 2017). "Hoʻomaʻamaʻa i nā kaikamahine a me nā keikikāne me McCune-Albright Syndrome me Precocious Puberty - Hoʻohou 2017". Nā Manaʻo Endocrinology Pediatric. 15 (2): 136–141.

[15] White R, Bradnam V (11 Malaki 2015). Handbook of Drug Administration via Enteral Feeding Tubes, 3rd edition. Paʻi Lapaʻau. aoao 108–.

[16] Serefoglu EC, Gokce A, Hellstrom WJ, Guay AT (2013). "ʻO nā mea lapaʻau ʻē aʻe no ka hoʻololi ʻana o Testosterone". ʻO Androgen Deficiency a me Testosterone Replacement. aoao 141–147.

5 Likes
13965 Views

E hiki no hoi i like

Comments ua paa.